Form 4: Arteris Inc. COO Laurent R. Moll Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on September 4th and 5th, 2024, to cover tax liabilities related to the release of restricted stock units.
Summary
- Laurent R. Moll, the Chief Operating Officer of Arteris, Inc., sold shares of the company's common stock on September 4th and 5th, 2024.
- The sales were executed to satisfy tax obligations arising from the release of restricted stock units.
- On September 4, 2024, 37,561 shares were sold at a price of $7.4915 per share.
- On September 5, 2024, 12,488 shares were sold at a weighted average price of $7.2554, with individual transactions ranging from $7.14 to $7.51.
- Following these transactions, Moll directly owns 531,980 shares of Arteris, Inc.
- The sale on September 5th was executed under a pre-arranged 10b5-1 trading plan adopted on March 15, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sales appear to be routine and related to tax obligations, so the sentiment is neutral.
Industry Context
Insider sales are a common occurrence, especially to cover tax obligations related to equity compensation. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on current market information.
Comparison to Industry Standards
- It is common for executives at publicly traded companies, such as Arteris, to utilize 10b5-1 trading plans to sell shares, especially to cover tax obligations related to equity compensation.
- Companies like ARM Holdings and Cadence Design Systems also have executives who periodically sell shares for similar reasons.
- The volume of shares sold by Laurent R. Moll is relatively small compared to the total outstanding shares of Arteris, Inc.
Stakeholder Impact
- The stock sales could have a minor negative impact on shareholder sentiment, but the effect is likely to be minimal given the reason for the sales and the existence of a 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| March 15, 2024 | Date of adoption of the 10b5-1 trading plan. |
| September 4, 2024 | Date of first stock sale (37,561 shares). |
| September 5, 2024 | Date of second stock sale (12,488 shares). |
| September 6, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.